Pancreatobiliary Carcinoma — Trials

Pancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,131 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 699
Recruiting: 403
Ph III recruiting: 36
Growth YoY: +23.4%
Industry share: 30%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (303)

clinicaltrialsPublishedShowing 101–150 of 357 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06710132	Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)	active not recruiting	Phase 1 / Phase 2	184	EMD Serono Research & Development Institute, Inc.INDUSTRY	10	Jul 30, 2026	clinicaltrials
NCT07285044	The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas	recruiting	Phase 2	27	Mayo ClinicOTHER	1